Search results
The Unexpected Reason Gilead Just Notched Its Biggest Single-Day Move In A Month
Investor's Business Daily· 8 months agoInvestors don't fully appreciate Gilead Sciences' leadership in HIV treatment, an analyst said...
Gilead profit tops expectations despite lower COVID drug sales, outlook raised
Reuters via Yahoo Finance· 2 years agoGilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of...
Gilead (GILD) Outperforms YTD: Will It Retain the Momentum?
Zacks via Yahoo Finance· 1 year agoGilead Sciences, Inc. GILD is having a good run as shares have gained 15.1% in the year so far...
Gilead (GILD) Outperforms Industry in 6 Months: What Lies Ahead?
Zacks via Yahoo Finance· 5 months agoGilead Sciences, Inc.’s GILD shares have gained 3.7% in the past six months against the industry’s...
Gilead (GILD) Up 2.6% in 3 Months: Will the Momentum Continue?
Zacks via Yahoo Finance· 2 years agoShares of Gilead Sciences, Inc. GILD has gained 2.6% in the past three months against the industry’s...
Gilead Sciences (GILD) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Gilead Sciences (NASDAQ: GILD) Q3 2022 Earnings Call Oct 27, 2022,...
Gilead (GILD) Gets FDA Nod for Twice-Yearly HIV Treatment
Zacks via Yahoo Finance· 1 year agoGilead'ls (GILD) HIV franchise gets a boost with FDA's approval of twice-yearly HIV treatment...
Gilead (GILD) Announces Positive New Data on Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD has announced positive new data from a post hoc subgroup analysis from...
Gilead (GILD) Gets EC Approval for Biktarvy Label Expansion
Zacks via Yahoo Finance· 1 year agoGilead Sciences, Inc. GILD announced that the European Commission (EC) has authorized a new low-dose...
Gilead (GILD) Q3 Earnings & Sales Top, Guidance Raised
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD reported better-than-expected third-quarter results, driven by continued...